Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify, Tylenol autism cases, Jardiance cases connected to Fournier gangrene, or any other anti-psychotic medication cases. Thank you.
Select Page

Mass Tort Litigation Updates: September 2024

2 minute read

When you’ve suffered an injury or illness due to a defective drug, our drug injury attorneys at Michael Brady Lynch Firm hold big pharmaceutical companies responsible for their negligent behavior and failure to warn consumers about dangerous products. In the past few months, there have been significant updates to several of the most prominent mass tort cases currently in litigation. If you’ve experienced illnesses related to the use of the drugs listed below, call us at 888-585-5970 to discuss your case.

Paragard

Victims have sued Paragard manufacturer Teva Pharmaceuticals for damages related to injuries related to arm breakage during the IUD’s removal. These injuries include uterine infections, infertility, PID, and uterine wall penetration. In some cases, women must have invasive surgeries, such as total hysterectomies, to remove the broken IUD safely.

The Paragard defense team filed a motion on September 12, 2024, to dismiss 236 complaints due to the statute of limitation requirements in six states and by the statute of repose in four other states. The defendants also sought to dismiss 26 other complaints for inaccurate or incomplete information regarding the Paragard placement and removal dates. These complaints may be amended if they aren’t entirely dismissed first. The first bellwether trial is set for October 28th. There are currently 2,793 cases as part of the MDL as of September 2024.

Camp Lejeune

Military members and civilians who lived or worked at Camp Lejeune, North Carolina, between 1953 and 1987 may have experienced adverse health effects due to contaminated water, such as kidney cancer, bladder cancer,  breast cancer, myeloma, leukemia, Hodgkin’s lymphoma, Parkinson’s, ALS, and birth defects.

In 2022, President Biden signed the Camp Lejeune Justice Act, which allowed former base residents to file claims for injuries related to water contamination with a two-year look-back window. This window closed on August 10th, so we can no longer accept Camp Lejeune cases. More than 320,000 cases have been filed against the U.S. Navy.

As litigation moves forward, the first trial won’t be held until 2026. This delayed timeline and the restriction of only allowing bench trials have plaintiff legal teams suggesting settlement may be the best course of action for victims.

Elmiron

Several medical studies have linked Elmiron (the brand name of Pentosan) to vision problems like pigmentary maculopathy and macular degeneration. Many Emiron patients are unaware they are suffering from a macular disorder, assuming their vision is deteriorating with age. Litigation for Elmiron cases has decreased over the last few months, with 1,454 active cases, down from the total record of 1,983. This may mean cases are settling privately and confidentially. Litigation is expected to end soon and settle. If you experienced vision problems after taking Elmiron, now is the time to file your claim before a deadline is set and the case settles. Contact our team to learn more.

Ozempic

The MDL against Ozempic is in the early stages of litigation. Recently, new reports have linked Ozempic usage with Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), also referred to as eye stroke. Symptoms include sudden blurry vision, losing vision in one eye, and experiencing dark spots or floaters. Blindness is also a side effect. Due to these new reports, we are now accepting cases of victims who suffered blindness or eye stroke after taking Ozempic.

Michael Brady Lynch Law Firm: Drug Injury Attorneys

Drug manufacturers should be held accountable for defective products. If you’ve suffered symptoms related to the drugs above, contact our Michael Brady Lynch Firm at 888-585-5907 for a free consultation to discuss your case. You don’t pay us any fees unless we recover for you. It’s time you receive the compensation you deserve for your injuries.

If you or a loved one have been diagnosed with vision problems due to Ozempic or Elmiron use or suffered fertility problems due to Paragard, please give us a call at the Michael Brady Lynch Firm at 888-585-5970 or email us at brandon@mblynchfirm.com.

Ormond Beach Abuse Investigation: Riverbend Academy

Ormond Beach Abuse Investigation: Riverbend Academy

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
PFAS Lawsuit 2025 Update: What You Should Know

PFAS Lawsuit 2025 Update: What You Should Know

The PFAS multidistrict litigation (MDL No. 2873) is moving forward in the District of South Carolina, where over 10,000 cases remain active against major manufacturers like 3M, DuPont, and BASF. While 3M reached a $10 billion settlement in 2023 to resolve water utility claims, no global settlement has been reached for individual personal injury lawsuits.

read more
Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax (alendronate), a widely used osteoporosis drug, remains the subject of multidistrict litigation (MDL) over allegations that it can cause serious bone injuries, including atypical femur fractures and osteonecrosis of the jaw (ONJ). Plaintiffs claim Merck failed to warn users adequately about these risks.

read more
Paragard MDL Updates: What You Should Know

Paragard MDL Updates: What You Should Know

The Paragard IUD remains the subject of a major nationwide lawsuit, with claims alleging the device breaks during removal, leading to serious injuries that the manufacturers, Teva Pharmaceuticals, allegedly failed to adequately warn consumers about. These cases have been centralized in Multidistrict Litigation (MDL) No. 2974, in the Northern District of Georgia.

read more
Understanding the Pre-Litigation Process: What to Do After a Car Accident

Understanding the Pre-Litigation Process: What to Do After a Car Accident

The time period immediately following a car accident is crucial not only for your health, but for protecting your legal rights. Prior to any lawsuits being filed, you enter the pre-litigation phase during which critical steps must be taken. Knowing what to do after an accident can make a major difference in the outcome of your personal injury claim and help preserve your right to compensation.

read more
The Car Accident Negotiation Phase

The Car Accident Negotiation Phase

The negotiation phase after a car accident is often the toughest part of resolving your claim. Insurance companies are skilled at minimizing payouts and may challenge the seriousness of your injuries, the necessity of your medical treatment, or the legitimacy of your lost wages. Getting through this process requires more than patience, it demands strong documentation and experienced legal representation.

read more
×
What Our Clients Are Saying